Revelation Biosciences, Inc. REVB
4.12 USD -0.31 (-7.05%)
At closeNov 4, 2026, 4:00 PM EST
3.90 -0.22 -5.41%
After hours · Nov 4, 4:00 PM ET
3.85 Day range 4.43
3.08 52-week range 40.60
- YTD
- +28.68%
- 1 year
- -6.42%
Financial health
Altman Z-Score
-7.61 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
Valuation
P/E -0.1×
FY 2019 5y median -4.0× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 0.2×
FY 2019 5y median 3.2× FY 2025
P/FCF -0.2×
FY 2019 5y median -3.8× FY 2025
EV/EBITDA 0.9×
FY 2019 5y median -3.4× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -416.3%
FY 2019 5y median -26.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -100.6%
FY 2019 5y median -100.6% FY 2025
ROIC -94.4%
FY 2019 5y median -130.2% FY 2025
ROA -77.0%
FY 2019 5y median -196.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -13.7%
FY 2019 FY 2025
EPS (diluted) 72.7%
FY 2019 FY 2025
Free Cash Flow 54.9%
FY 2019 FY 2025
Financial Health
Current Ratio 5.4×
FY 2019 5y median 2.2× FY 2025
Quick Ratio 5.4×
FY 2019 5y median 2.2× FY 2025
Debt / Equity 0.1×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 1.1×
FY 2019 5y median 0.8× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31